Thursday, July 09, 2026 | 06:08 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Page 3 - Ebitda

Signature Global Q3FY25 results: Revenue grows multifold to Rs 830 crore

The company's PAT for Q3FY25 stood at almost Rs 29 crore, against just Rs 2 crore in Q3FY24

Signature Global Q3FY25 results: Revenue grows multifold to Rs 830 crore
Updated On : 10 Feb 2025 | 8:48 PM IST

Tata Chemicals hits 52-week low on Q3 loss, weak margin; analysts cautious

The Q3FY25 results saw Tata Chemicals report a net loss of Rs 53 crore, from Rs 158 crore profit in Q3FY24

Tata Chemicals hits 52-week low on Q3 loss, weak margin; analysts cautious
Updated On : 04 Feb 2025 | 12:11 PM IST

Adani group-promoted Ambuja Cements a hot pick despite margin pressure

Consolidated revenue was at Rs 8,500 crore, with adjusted EBITDA at Rs 890 crore, and adjusted PAT at Rs 410 crore in Q3FY25

Adani group-promoted Ambuja Cements a hot pick despite margin pressure
Updated On : 31 Jan 2025 | 12:26 AM IST

Tata Motors Q3 disappoints, analysts lower targets, ratings; stock tanks 9%

Tata Motors' consolidated profit for Q3FY25 fell 22.4 per cent year-on-year (Y-o-Y) to Rs 5,451 crore, from Rs 7,025 crore in Q3FY24

Tata Motors Q3 disappoints, analysts lower targets, ratings; stock tanks 9%
Updated On : 31 Jan 2025 | 12:11 AM IST

Airtel Africa Q3 results: Net profit rises to $133 million, revenue up 2%

Appreciation in key currencies give exceptional gain of $94 million to company

Airtel Africa Q3 results: Net profit rises to $133 million, revenue up 2%
Updated On : 30 Jan 2025 | 11:04 PM IST

Biocon Q3 results: Net profit at Rs 25 cr, revenue at Rs 3,821 crore

It also reported a profit before tax (PBT) of Rs 155.9 crore, down 80.8 per cent in Q3FY25

Biocon Q3 results: Net profit at Rs 25 cr, revenue at Rs 3,821 crore
Updated On : 30 Jan 2025 | 10:25 PM IST

Dr Lal Q3FY25 results: PAT jumps 19% to Rs 98 crore as volumes grow

As for Suburban Diagnostics, an arm of Dr Lal Pathlabs, revenue growth was 9.2 per cent in Q3

Dr Lal Q3FY25 results: PAT jumps 19% to Rs 98 crore as volumes grow
Updated On : 30 Jan 2025 | 5:01 PM IST

Limited near-term upside in Hindustan Zinc stock; firm aiming for expansion

The improvement was due to higher metal grades and better domestic coal availability, supported by increased renewable energy

Limited near-term upside in Hindustan Zinc stock; firm aiming for expansion
Updated On : 30 Jan 2025 | 12:45 AM IST

Bajaj Auto Q3 FY25 results: Net profit rises 8% to Rs 2,196 crore

Chetak margins are out of red; exports touched 500K units after 9 quarters

Bajaj Auto Q3 FY25 results: Net profit rises 8% to Rs 2,196 crore
Updated On : 28 Jan 2025 | 11:00 PM IST

Dahlias super-luxury project lays strong growth foundation for DLF

DLF sold 173 units with a total area of 1.85 million square feet (msf) at an average realisation of Rs 70 crore per residence

Dahlias super-luxury project lays strong growth foundation for DLF
Updated On : 28 Jan 2025 | 10:47 PM IST

JSW Infra Q3FY25 results: Net profit grows 31% amid higher cargo volumes

In Q3 FY25, the company handled cargo volumes of 29.4 million tonnes, up 5 per cent Y-o-Y

JSW Infra Q3FY25 results: Net profit grows 31% amid higher cargo volumes
Updated On : 28 Jan 2025 | 9:22 PM IST

Hindustan Zinc shares up 13% in two weeks, rally likely to continue

Company's cost-saving measures and debt reduction expected to boost company's margin

Hindustan Zinc shares up 13% in two weeks, rally likely to continue
Updated On : 24 Jan 2025 | 1:26 PM IST

Demand woes likely to keep a lid on Hindustan Unilever stock in near term

Among business segments, Home Care remains the best performer with Beauty & Wellbeing (B&W) segment the weakest

Demand woes likely to keep a lid on Hindustan Unilever stock in near term
Updated On : 23 Jan 2025 | 11:37 PM IST

Q3 results preview: Weak O2C biz likely to drag earnings for RIL again

Analysts expect Q3FY25 to report continued weakness in O2C earnings

Q3 results preview: Weak O2C biz likely to drag earnings for RIL again
Updated On : 15 Jan 2025 | 3:18 PM IST

Nuvama positive on NSE, BSE growth despite volume dip in F&O segment

Sebi's proposal on dilution of stake in clearing corporations to hit financials, says report

Nuvama positive on NSE, BSE growth despite volume dip in F&O segment
Updated On : 14 Jan 2025 | 11:04 PM IST

Adani Group firms' balance sheet improved in 2 years; debt rose: Bernstein

Debt burden primarily on Adani Enterprises; group's cash reserve has increased 75% since March 2023

Adani Group firms' balance sheet improved in 2 years; debt rose: Bernstein
Updated On : 03 Dec 2024 | 4:12 PM IST

Cipla promoters may sell 1.72% stake worth Rs 2,000 crore via block deal

The floor price for the Cipla share sale has been set at Rs 1,442 per share, reflecting a 6 per cent discount to the current market price

Cipla promoters may sell 1.72% stake worth Rs 2,000 crore via block deal
Updated On : 29 Nov 2024 | 11:11 PM IST

ShareChat's adjusted Ebitda losses fall 67% to Rs 793 crore in FY24

Homegrown social media company ShareChat on Tuesday said its adjusted EBITDA losses fell by 67 per cent year-on-year to Rs 793 crore in FY24, amid 33 per cent growth in revenue. The company further said it is on track for a cash breakeven by March 2025. With improved financial metrics, the company expects to start investing back into growth and is on "actively" lookout for inorganic opportunities through acquisitions. Organic growth will happen through the expansion of the user base and increasing revenue per user. ShareChat has social media brands such as ShareChat app and Moj under its portfolio. While the company is sufficiently capitalised for now, it is looking at "adding more people to cap table ahead of preparations for IPO journey". It is eyeing timelines of 18-24 months for a possible IPO, depending on market conditions. "We will try and do one more funding round before we do IPO...possibly next year... but we don't need capital so we will time it based on interest in the

ShareChat's adjusted Ebitda losses fall 67% to Rs 793 crore in FY24
Updated On : 26 Nov 2024 | 4:25 PM IST

HealthCare Global to sell diagnostic business Triesta for Rs 135 crore

HCG reported a consolidated net profit of Rs 20.68 crore in the second quarter of financial year 2025, as against Rs 10.78 crore in the same quarter of the previous year

HealthCare Global to sell diagnostic business Triesta for Rs 135 crore
Updated On : 11 Nov 2024 | 7:20 PM IST

Simplilearn cuts Ebitda losses by 75% as FY24 revenue reaches Rs 773 crore

The company's strategic emphasis on high-demand products within key growth markets has effectively addressed the evolving skill enhancement needs of professionals

Simplilearn cuts Ebitda losses by 75% as FY24 revenue reaches Rs 773 crore
Updated On : 07 Nov 2024 | 6:51 PM IST